3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
17
Gastrointestinal
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Other
1
Myeloid
1
Lymphoid
1
Genitourinary
1
CNS
1
Conditions
Obesity
20
Mucositis
19
Constipation
13
Neoplasms
11
Opioid-Induced Constipation
9
Pain
8
Overweight
6
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Sexual Dysfunction, Physiological
4
Bronchiolitis Obliterans Syndrome
4
Xerostomia
3
Stomatitis
3
Radiation Injuries
3
Polycystic Ovary Syndrome
3
Endometrial Neoplasms
3
Breast Neoplasms
3
Sedentary Behavior
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Multiple Myeloma
2
Glucose Intolerance
2
Dyspnea
2
Chemotherapy-induced Peripheral Neuropathy
2
Venous Thromboembolism
1
Urinary Incontinence
1
Thyroid Diseases
1
Stomach Ulcer
1
Stomach Neoplasms
1
Interventions
Dalteparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Venous Thromboembolism
×
Other
×
Clear all
NCT03297359
2024-01-23
WAVe
Ottawa Hospital Research Institute
Phase 2
Terminated
92 enrolled